Attendees will leave with an understanding of the best practices employed by lawyers and consultants in guiding businesses through these complicated applications, in particular how to assist one client in securing licenses in multiple states with varying qualification standards.
With a new Administration and Congress, changes in personnel at FDA and new safety data being published, is 2021 the year when CBD will come out from under the FDA shadows to be legally marketed in all 50state?
This panel seeks to get to the bottom of the IFR and what it means for the hemp CBD industry currently and in the future. We may also touch on the intersection of USDA and FDA authority to regulate hemp-derived CBD products.
Using the current regulatory landscape of CBD as a jumping-off point, this panel will explore this new market from a regulatory standpoint. We will discuss what these cannabinoids are and how they are likely to be used; whether they will encounter similar regulatory obstacles as CBD in coming to market; and whether we should continue to think of cannabinoids as a unified “block” for regulatory purposes,or if they will each have separate paths.
With the 2018 Farm Bill well under our belts, and implementation of the USDA Rules well underway, let’s take a look at how the world is changing under the new regime. The sunset of the old administrative regimes left over from the 2014 Farm Bill and the rise of the 2018 Farm Bill regulations have created a new way to navigate the hemp industry. Join us to take a look at the terrain ahead.